In some lupus models (e.g. the NZB x NZW F1 mouse), reduced levels of TNF-α are observed, and replacement therapy with recombinant TNF-α induces a significant delay in the development of nephritis [57]. Here, TNF is linked to systemic lupus erythematosus.